CANCER RISK IN CROHN’S DISEASE PATIENTS TREATED OR UNTREATED WITH INFLIXIMAB: A MULTICENTER MATCHED-PAIR STUDY FROM 1999 TO 2008

(1) INTERNAL MEDICINE, GASTROENTEROLOGY, UNIVERSITA' TOR VERGATA, Rome, Italy



This item was part of the Anti TNF therapy in IBD: Current to future session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A71